Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARR2: Blood-Eosinophil Directed Corticosteroid Therapy for COPD Exacerbations
NCT04458636Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Nov 2017
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone in chronic obstructive pulmonary disease (COPD), sponsored by University of Oxford. Started Nov 2017; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04458636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04458636.